DSOL (Drug Free Solution) Gross Profit: $0.00 Mil (TTM As of Feb. 2014)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Drug Free Solution Gross Profit?

Drug Free Solution DSOL +100.00% Gross Profit is $0.00 Mil as of Feb. 2014.

Drug Free Solution's gross profit for the three months ended in Feb. 2014 was $0.00 Mil. Drug Free Solution's gross profit for the trailing twelve months (TTM) ended in Feb. 2014 was $0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Drug Free Solution's gross profit for the three months ended in Feb. 2014 was $0.00 Mil. Drug Free Solution's Revenue for the three months ended in Feb. 2014 was $0.00 Mil. Therefore, Drug Free Solution's Gross Margin % for the quarter that ended in Feb. 2014 was N/A%.

Drug Free Solution had a gross margin of N/A% for the quarter that ended in Feb. 2014 => No sustainable competitive advantage


Drug Free Solution  (OTCPK:DSOL) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Drug Free Solution had a gross margin of N/A% for the quarter that ended in Feb. 2014 => No sustainable competitive advantage


Drug Free Solution Gross Profit Related Terms


Drug Free Solution Gross Profit Historical Data

* Premium members only.

The historical data trend for Drug Free Solution's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drug Free Solution Gross Profit Chart

Drug Free Solution Annual Data
Trend May12 May13
Gross Profit
0.00 0.00

Drug Free Solution Quarterly Data
Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DSOL vs USEL, ZZLL, WSCO: Gross Profit Comparison

For the Health Information Services subindustry, Drug Free Solution's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Drug Free Solution Gross Profit vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Drug Free Solution's Gross Profit distribution charts can be found below:

* The bar in red indicates where Drug Free Solution's Gross Profit falls into.



Drug Free Solution Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Drug Free Solution's Gross Profit for the fiscal year that ended in May. 2013 is calculated as

Gross Profit (A: May. 2013 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Drug Free Solution's Gross Profit for the quarter that ended in Feb. 2014 is calculated as

Gross Profit (Q: Feb. 2014 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Feb. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Drug Free Solution's Gross Margin % for the quarter that ended in Feb. 2014 is calculated as

Gross Margin % (Q: Feb. 2014 )=Gross Profit (Q: Feb. 2014 ) / Revenue (Q: Feb. 2014 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Profit →
What does a Gross Profit of $0.00 Mil mean?
Drug Free Solution (DSOL) has a Gross Profit of $0.00 Mil as of Feb. 2014. Gross Profit equals net sales less total cost of goods sold. View historical data on Drug Free Solution and its competitors.
Is Drug Free Solution's Gross Profit too high?
Drug Free Solution's current Gross Profit is $0.00 Mil.
How does Drug Free Solution's Gross Profit compare to USEL and ZZLL?
Drug Free Solution's Gross Profit of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Healthcare Providers & Services company?
A good Gross Profit depends on the Healthcare Providers & Services industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Drug Free Solution and its competitors. Drug Free Solution's current Gross Profit is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drug Free Solution stock overvalued right now?
Drug Free Solution (DSOL) has a current Gross Profit of $0.00 Mil. The current Gross Profit is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Drug Free Solution (DSOL), the current Gross Profit is $0.00 Mil as of Feb. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drug Free Solution Business Description

Address 2211 Michelson Drive, Irvine, CA, USA, 92612
Drug Free Solution Inc is a United States based holding company that owns and operates various subsidiaries in the healthcare industry. It is focused on acquiring healthcare operations that focus on Home Healthcare, Developmental Disabilities, Hospice Care, Skilled Nursing, Residential Rehabilitation, Home & Community Based Services.